Financhill
Back

Bio-Path Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
18

BPTH
Bio-Path Holdings

Last Price:
0.90
Seasonality Move:
-15.1%
Sell
45

NBY
NovaBay Pharmaceuticals

Last Price:
0.77
Seasonality Move:
-8.12%
Sell
18
Bio-Path Holdings (BPTH) is a Sell

Is Bio-Path Holdings a Buy, Sell or Hold?

  • The current Bio-Path Holdings [BPTH] share price is $0.98. The Score for BPTH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • BPTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.76. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPTH Stock Price Chart

What is Bio-Path Holdings's stock price today?

  • The Bio-Path Holdings share price today is $0.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPTH is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.

BPTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.61 Sell
Chaikin Money Flow: 25847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.93 - 1.13) Sell
Bollinger Bands (100): (0.95 - 1.79) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 63.12 Buy
Chaikin Money Flow: 100221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

BPTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.01 Sell
20-day SMA: 1.07 Sell
50-day SMA: 1.01 Sell
200-day SMA: 3.09 Sell
8-day EMA: 1 Sell
20-day EMA: 1.03 Sell
50-day EMA: 1.12 Sell
200-day EMA: 4.27 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.66 Buy
20-day SMA: 0.64 Buy
50-day SMA: 0.6 Buy
200-day SMA: 2.66 Sell
8-day EMA: 0.69 Buy
20-day EMA: 0.66 Buy
50-day EMA: 0.74 Buy
200-day EMA: 6.3 Sell

Bio-Path Holdings Earnings Growth & BPTH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $27.20 per share, and an increase next year of $2.16 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Bio-Path Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):